CCM
GPCR icon

Cinctive Capital Management’s Structure Therapeutics GPCR Stock Holding History

Cinctive Capital Management’s Portfolio GPCR Stock Details GPCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$420K Buy
+8,714
New +$596K 0.03% 308
2025
Q1 		– Sell
-9,065
Closed -$246K – 375
2024
Q4 		$246K Sell
9,065
-23,029
-72% -$817K 0.01% 337
2024
Q3 		$1.41M Buy
32,094
+16,883
+111% +$653K 0.08% 259
2024
Q2 		$597K Buy
+15,211
New +$625K 0.03% 343

Other funds holding GPCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Cinctive Capital Management's GPCR Position: Q1 2026 in Review

Cinctive Capital Management opened a new position in Structure Therapeutics (GPCR) in Q1 2026: 8,714 shares worth $420K. The stake represents 0.03% of the portfolio and ranks #308 among its holdings. This is a return to the name: Cinctive Capital Management previously reported a position in GPCR as recently as Q4 2024.

Cinctive Capital Management first reported a position in GPCR in Q2 2024 and has held it in 4 quarters since. The position peaked at $1.41M in Q3 2024. 196 funds tracked by Wall St. Rank hold GPCR as of Q1 2026.

  • Cinctive Capital Management held 8,714 shares of Structure Therapeutics worth $420K as of Q1 2026.
  • Structure Therapeutics was a new Cinctive Capital Management position in Q1 2026.
  • Structure Therapeutics made up 0.03% of Cinctive Capital Management's portfolio in Q1 2026, its #308 holding.
  • Cinctive Capital Management first reported a position in Structure Therapeutics in Q2 2024 and has held it in 4 quarters since.
  • Cinctive Capital Management's Structure Therapeutics position peaked at $1.41M in Q3 2024.
  • 196 funds tracked by Wall St. Rank held Structure Therapeutics as of Q1 2026.

Based on Cinctive Capital Management's 13F filing for Q1 2026, filed 15 May 2026.